PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Obstetrics and Gynecology, Akershus University Hospital, Nordbyhagen, Norway.\', \'Institute of Clinical Medicine, University of Oslo, Oslo, Norway.\', \'Department of Medical Biochemistry, Oslo University Hospital-Rikshospitalet, Oslo, Norway.\', \'Department of Microbiology and Infection Control, Akershus University Hospital, Nordbyhagen, Norway.\', \'Multidisciplinary Laboratory Medicine and Medical Biochemistry, Akershus University Hospital, Nordbyhagen, Norway.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1017/S0950268822000073
?:doi
?:hasPublicationType
?:journal
  • Epidemiology and infection
is ?:pmid of
?:pmid
?:pmid
  • 35022102
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.128
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Prevalence of antibodies against SARS-CoV-2 among pregnant women in Norway during the period December 2019 through December 2020.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35022102>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35022102>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all